Bugs/Drugs Flashcards
Name as many signs/sx of CAP as you can.
Fever/hypothermia Tachypnea Cough +/- sputum dyspnea chest discomfort sweats and or rigors tachypnea tachycardia O2 desaturation pleurisy hemoptysis fatigue Headache anorexia abdomen pain
Possible physical exam findings for CAP
Bronchial breath sounds, inspiratory crackles, dullness to percussion.
CXR findings for CAP
any of the following are possible:
Parenchymal opacity
patchy airspace opacities
lobar consolidation with air bronchograms
diffuse alveolar and interstitial opacities
CXR or CT required to establish diagnosis!
What is the best way to treat CAP
EMPIRICALLY - don’t wait for labs to come back, promptly initiate a drug, ideally one that the bug is susceptible to
When is diagnostic testing indicated?
Generally not, unless there is something funky in the history to make you suspect an atypical pneumonia or some other cause.
Diagnostic tests include sputum gram stain, urinary antigen tests (for S. pneumonia and legionella), and rapid antigen (influenza).
Patients who require hospitalization will require 2+ blood draws for culture from at least two sites.
How big a problem is CAP?
4-5 million cases per year, 25% of which require hospitalization.
Most deadly infectious disease, 8th leading cause of death!
What are the risk factors for CAP?
Advanced age Alcoholism Tobacco Use Comorbid Medical Conditions Immunosupression
Where/when does CAP occur?
Outside of the hospital/health care setting, or within 48 hours of admission.
What are two preventative measures for CAP?
Pneumococcal vaccine, flu shot
Empiric treatment for an outpatient CAP without recent antibiotic use?
Macrolide or doxy
Empiric treatment for an outpatient CAP with comorbid condition or recent antibiotic use?
Respiratory floroquinolone or macrolide + beta-lactam
Empiric therapy for an inpatient CAP who is NOT in the ICU
respiratory floroquinolone or macrolide+B-lactam
Empiric therapy for an inpatient CAP who IS in the ICU
Azithromycin or respiratory fluroquinolong +
antipneumococcal beta-lactam
Empiric therapy for an inpatient CAP who is in the ICU and at risk for pseudomonas?
Azithromycin or respiratory fluroquinolone
+antipneumococcal
+antipseudomal beta-lactam
+aminoglycoside
Empiric therapy for an inpatient CAP pt who is at risk for MRSA
Azithromycin or respiratory fluroquinolone
+vancomycin
How does HAP differ from CAP?
- Different infectious causes
- Different antibiotic susceptibility and increased resistance
- Patient’s underlying health status puts them more at risk